The global idiopathic pulmonary fibrosis market size was valued at USD 4.54 billion in 2024 and is projected to reach from ...
Stockhead on MSN1d
The ASX players bringing new hope to IPF sufferersIdiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...
Learn about idiopathic pulmonary fibrosis, its symptoms, diagnosis, and treatment options for managing this lung disease.
Pirfenidone use in patients with idiopathic pulmonary fibrosis may be linked to a lower incidence of lung cancer. Learn more.
The new chief medical officer of the Pulmonary Fibrosis Foundation speaks about patients in rural areas, research ...
GlobalData on MSN2d
Qureight and Remedy Cell to validate RC-0315 in Phase Ib trial for IPFQureight and Remedy Cell have collaborated to validate the mechanism of action of RC-0315 in the Phase Ib clinical trial for ...
She cited her mum Amy's battle with idiopathic pulmonary fibrosis, a terminal lung disease, as the reason behind her decision. 'I have a big confession to make, and if there's anyone out there ...
The UK IPF Registry has provided new insights into the evolving landscape of idiopathic pulmonary fibrosis management.
Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback